71
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Docetaxel and Its Nanoformulations: How Delivery Strategies Could Impact the Therapeutic outcome?

, , & ORCID Icon
Pages 755-759 | Received 26 Jul 2020, Accepted 12 Aug 2020, Published online: 01 Sep 2020
 

Financial & competing interests disclosure

SERB-Department of Science and Technology (DST) (YSS/2014/000521) and DST-Rajasthan (S.No. P7(3)/VPro./RandD/2016/3228) is duly acknowledged for the financial support to D Chitkara. Council for Scientific and Industrial Research (CSIR) (File no 09/719(0087)/2018-EMR-1) is duly acknowledged for senior research fellowship (SRF) to S Sharma. The authors (D Chitkara and A Mittal) are the founding directors of Nanobrid Innovations Private Limited, India, that is involved in the development of nanotechnology-based products. They have a business and/or financial interest in the operations of the company. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 351.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.